Senator John Breaux (D-LA)
|
| |
The creation of the Rx Benefits Coalition to promote
the use of private sector tools in the management of pharmacy benefits
is coming at a critical and needed time in the health care debate.
Today's challenges stem from an increasing demand for more and better
pharmaceuticals: We need to preserve drug development and medical
innovation; we need to ensure that drugs are properly and safely
used; and we need to control costs. Affordability, innovation and
safety are the cornerstones of the sound pharmacy management services
being advocated by the RxBC. I applaud the group's formation, and
believe the RxBC will help inform the public debate on these crucial
issues. |
| |
|
House Ways and Means Health Chairperson Nancy Johnson (R-CT):
|
| |
"Prescription drugs are a critical part of patient
care today, and their use will only grow as new pharmaceuticals
for unmet medical needs are approved. This means the management
of both the cost and use of prescription drugs will only become
more important. I commend the members of the Rx Benefit Coalition
for organizing to ensure that we can manage patients' diseases more
effectively in the future." |
| |
|
House Energy and Commerce Committee Chairman Billy Tauzin (R-LA):
|
| |
I applaud the formation of the Rx Benefits Coalition
and its goal of ensuring that consumers have access to safe and
affordable prescription drugs. I strongly support the use of market-based
tools to improve the delivery of pharmaceuticals to patients and
will look forward to working with the members of the Coalition as
Congress develops a new prescription drug benefit for Medicare beneficiaries. |
| |
|
House Ways and Means Committee Chairman Bill Thomas (R-CA):
|
| |
"Formation of the Rx Benefits Coalition will promote
the use of private sector tools to manage of pharmacy benefits.
It is important that the businesses that manage patient pharmacy
needs contribute to the debate, particularly as we work to develop
a prescription drug benefit in a modernized Medicare program. We
will be relying on their ability to restrain costs, improve patient
care and ensure the safe and effective use of prescription drugs.
It's high time that there was a new voice contributing to the discussion." |
| |
|
